Radiprodil misses neuropathic pain endpoint

Forest Laboratories Inc. (NYSE:FRX) and Gedeon Richter Ltd. (Budapest:RICHTER) said late Monday that top-line data showed radiprodil ( RGH-896) missed the primary endpoint in a Phase II trial to treat...